ALGAE TEC LTD/S (OTCMKTS:ALGXY) and Geovax Labs (OTCMKTS:GOVX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.
This table compares ALGAE TEC LTD/S and Geovax Labs’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|ALGAE TEC LTD/S||N/A||N/A||N/A|
This is a breakdown of current recommendations and price targets for ALGAE TEC LTD/S and Geovax Labs, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|ALGAE TEC LTD/S||0||0||0||0||N/A|
Risk and Volatility
ALGAE TEC LTD/S has a beta of 73.43, meaning that its stock price is 7,243% more volatile than the S&P 500. Comparatively, Geovax Labs has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500.
Institutional & Insider Ownership
0.1% of ALGAE TEC LTD/S shares are held by institutional investors. Comparatively, 0.1% of Geovax Labs shares are held by institutional investors. 2.1% of Geovax Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares ALGAE TEC LTD/S and Geovax Labs’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|ALGAE TEC LTD/S||$2.05 million||1.03||-$6.08 million||N/A||N/A|
|Geovax Labs||$1.08 million||5.60||-$2.17 million||($0.03)||-0.87|
Geovax Labs has lower revenue, but higher earnings than ALGAE TEC LTD/S.
ALGAE TEC LTD/S beats Geovax Labs on 5 of the 8 factors compared between the two stocks.
About ALGAE TEC LTD/S
Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.
About Geovax Labs
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines for infectious diseases and cancer in the United States and internationally. The company through its patented Modified Vaccinia Ankara-Virus Like Particle vaccine platform develops various vaccines. It is developing various vaccines that are in human clinical trials, and preclinical research and development phases, including vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; United States Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; Peking University; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.
Receive News & Ratings for ALGAE TEC LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALGAE TEC LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.